Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Gross Profit (2017 - 2025)

Historic Gross Profit for Agios Pharmaceuticals (AGIO) over the last 8 years, with Q4 2025 value amounting to $18.1 million.

  • Agios Pharmaceuticals' Gross Profit rose 9100.32% to $18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.7 million, marking a year-over-year increase of 4747.47%. This contributed to the annual value of $47.7 million for FY2025, which is 4747.47% up from last year.
  • Agios Pharmaceuticals' Gross Profit amounted to $18.1 million in Q4 2025, which was up 9100.32% from $11.2 million recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Gross Profit ranged from a high of $18.1 million in Q4 2025 and a low of $493000.0 during Q1 2022
  • For the 4-year period, Agios Pharmaceuticals' Gross Profit averaged around $7.3 million, with its median value being $6.9 million (2023).
  • Per our database at Business Quant, Agios Pharmaceuticals' Gross Profit soared by 92535.5% in 2023 and then soared by 104.47% in 2025.
  • Over the past 4 years, Agios Pharmaceuticals' Gross Profit (Quarter) stood at $3.9 million in 2022, then soared by 67.23% to $6.5 million in 2023, then soared by 45.31% to $9.5 million in 2024, then skyrocketed by 91.0% to $18.1 million in 2025.
  • Its last three reported values are $18.1 million in Q4 2025, $11.2 million for Q3 2025, and $10.8 million during Q2 2025.